麻豆传媒

Tirzepatide ok'd for obstructive sleep apnea in people with obesity

Compounders only have 2 to 3 months left to copy injectable

Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide

"Weight is multifactorial," researcher noted

麻豆传媒 analysis finds large increases in prescribing of GLP-1 agonists

Plus: oral semaglutide outcomes and incident hypertension in teens on GLP-1 drugs

Labels now caution about pulmonary aspiration risk

Diagnoses were also delayed the longer sugar was restricted

Randomized trial achieves a substantial impact with personalized texting, goal-based feedback

Remission of coexisting conditions was also maintained, long-term data show

GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions

Including lipids did not prove superior to non-laboratory-based criteria alone, study finds

Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections

I anticipate benefits outweighing potential risks in only a select few situations